Impact of High-Sensitivity C-Reactive Protein on Coronary Artery Disease Severity and Outcomes in Patients Undergoing Percutaneous Coronary Intervention
Coronary artery disease (CAD) is a leading cause of mortality and morbidity worldwide.
Coronary artery disease (CAD) is a leading cause of mortality and morbidity worldwide.
A risk factor in the vulnerability and extremity of pulmonary arterial hypertension (PAH) is sex difference.
Cardiovascular disease (CVD) is the leading cause of death in South Korea and is the cause of significant societal burdens worldwide too.
Advances in the management of children and adults with congenital heart disease (CHD) have had a major impact on long-term survival, such that the projected number of adults with CHD in Europe and North America now exceeds 3.5 million.
Coronary artery disease (CAD) is believed to underlie 60–80% of these deaths.
Preparticipation evaluation (PPE) offers the potential to prevent sudden cardiac death (SCD) in young athletes by early identification of cardiac diseases at risk of malignant ventricular arrhythmias (VA).